Under the agreement Menarini’s OTC Division is granted exclusive rights to market and sell Emtrix under the trademark YouDerm Emtrix.
Moberg Derma president and CEO Peter Wolpert said that the agreement is part of their international commercialization of Emtrix.
"As the leading Italian pharmaceutical group, ranked 34th in the world, Menarini is well positioned to make Emtrix a success in Italy," Wolpert added.